TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 36 filers reported holding TENAX THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $16,000 | +33.3% | 32,140 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $12,000 | -50.0% | 32,140 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $24,000 | +33.3% | 32,140 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $18,000 | -71.4% | 32,140 | 0.0% | 0.00% | -60.0% |
| Q4 2016 | $63,000 | -14.9% | 32,140 | 0.0% | 0.01% | -37.5% |
| Q3 2016 | $74,000 | -9.8% | 32,140 | 0.0% | 0.01% | -20.0% |
| Q2 2016 | $82,000 | +24.2% | 32,140 | 0.0% | 0.01% | -9.1% |
| Q1 2016 | $66,000 | -37.1% | 32,140 | 0.0% | 0.01% | -45.0% |
| Q4 2015 | $105,000 | +34.6% | 32,140 | +25.4% | 0.02% | 0.0% |
| Q3 2015 | $78,000 | -46.2% | 25,640 | -34.6% | 0.02% | -20.0% |
| Q2 2015 | $145,000 | -4.0% | 39,175 | -15.2% | 0.02% | +38.9% |
| Q1 2015 | $151,000 | -14.7% | 46,175 | 0.0% | 0.02% | -55.0% |
| Q4 2014 | $177,000 | -10.2% | 46,175 | -7.7% | 0.04% | +42.9% |
| Q3 2014 | $197,000 | – | 50,025 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,108,593 | $3,326,000 | 1.32% |
| RA Capital Management | 2,670,300 | $8,011,000 | 1.15% |
| Opaleye Management Inc. | 635,000 | $1,905,000 | 0.94% |
| Broadfin Capital, LLC | 1,968,631 | $5,906,000 | 0.33% |
| SABBY MANAGEMENT, LLC | 2,604,660 | $7,892,000 | 0.32% |
| DAFNA Capital Management LLC | 81,509 | $245,000 | 0.24% |
| ARMISTICE CAPITAL, LLC | 88,739 | $266,000 | 0.09% |
| BOURGEON CAPITAL MANAGEMENT LLC | 17,500 | $52,000 | 0.04% |
| Verition Fund Management LLC | 25,640 | $78,000 | 0.02% |
| COMMERZBANK AKTIENGESELLSCHAFT /FI | 738,592 | $2,216,000 | 0.02% |